Himanshu Nagar MD MS
[Pronunciation: Himanshu Nagar]
Urologic Cancer
Director of Genitourinary Program at Memorial Sloan Kettering, Department of Radiation Oncology
530 East 74th StreetNew York, NY 10021
Overview of Dr. Nagar
Dr. Himanshu Nagar is a board certified radiation oncologist who specializes in caring for patients with genitourinary malignancies.
Dr. Nagar received his undergraduate degree from Johns Hopkins University, his medical degree from the University of Texas Health Science Center at Houston and completed his residency at NewYork-Presbyterian Hospital/Weill Cornell Medicine where he served as the Chief Resident in his final year. Dr. Nagar is the recipient of numerous honors, including the Physician of the Year Award from NewYork-Presbyterian Hospital along with multiple research grants, scholarships and awards.
Dr. Nagar is actively involved in both translational and clinical research. Dr. Nagar is focused on better defining and tailoring the role of radiation therapy for prostate, bladder, and kidney cancers.
Clinical Expertise
- Prostate cancer, Kidney cancer, Bladder cancer
Education & Training
Cornell UniversityMS, Clinical and Translational Investigation, 2019 - 2024
New York-Presbyterian Hospital (Cornell Campus)Chief Residency, Radiation Oncology, 2014 - 2015- New York-Presbyterian Hospital (Cornell Campus)Residency, Radiation Oncology, 2011 - 2014
- New York Presbyterian HospitalInternship, Transitional Year, 2010 - 2011
McGovern Medical School at UTHealthClass of 2010
Johns Hopkins UniversityB.A., Dual Degrees (Biology/Economics), 1995 - 1999
Work Experience
Memorial Sloan Kettering Cancer Center (New York, NY)Director Of Genitourinary Program, Department Of Radiation Oncology · July 2024 - Current
NewYork-Presbyterian Brooklyn Methodist Hospital (Brooklyn, NY)Assistant Professor · October 2022 - July 2024
New York-Presbyterian Hospital (New York, NY)Assistant Professor · August 2015 - July 2024
Weill Cornell MedicineAssistant Professor · August 2015 - July 2024
University of Texas M.D. Anderson Cancer Center (Houston, TX)Research Fellow · January 2007 - January 2010
Baylor College of MedicineResearch Fellow · January 2002 - January 2006
Johns Hopkins Hospital (Baltimore, MD)Research Fellow · January 1997 - January 1998
Certifications & Licensure
FL State Medical License 2022 - Present
NY State Medical License 2014 - 2027
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Excellence in Research Award New York Presbyterian Hospital/Weill Cornell Medical College, 2012
- Physician of the Year New York Presbyterian Hospital/Weill Cornell Medical College, 2013
- Educational Grant American Brachytherapy Society, 2014
- Join now to see all
Clinical Trials
- PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT) Start of enrollment: 2018 Oct 24
- Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks Start of enrollment: 2020 Sep 24
- Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer Start of enrollment: 2022 Feb 11
- Join now to see all
Publications & Presentations
PubMed
- Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer.Soumyajit Roy, Yilun Sun, James A Eastham, Martin Gleave, Christopher J D Wallis
European Urology Oncology. 2025-07-18 - 2 citationsNational Cancer System Characteristics and Prostate Cancer Outcomes: An Analysis of Global Data.Edward Christopher Dee, Ranvir Iyengar, Aditya Narayan, Erin Jay G Feliciano, James Fan Wu
The Prostate. 2025-07-01 - 1 citationsA Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointesti...Himanshu Nagar, Marshall A Diven, Brady Rippon, Christopher E Barbieri, Jim C Hu
European Urology Oncology. 2025-06-09
Press Mentions
NRG Oncology Opens New “ARCHER” Clinical Trial (NRG-GU015) Testing a Shorter Treatment Duration of Radiation Therapy for Muscle Invasive Bladder CancerAugust 14th, 2025- Artera Achieves Nationwide Access for Its ArteraAI Prostate Test with New York State LicenseJune 10th, 2025
- Doubling of Radical Surgery Rates for High-Risk Prostate Cancer ReportedSeptember 9th, 2020
- Join now to see all
Grant Support
- ESCAPE - Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancerWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
- ESCAPE - Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancerNational Cancer Institute2024–Present
Research History
- Research FellowMD Anderson Cancer Center - Department of Radiation Oncology2007 - 2010
- Research FellowBaylor College of Medicine - Department of Cardiology2002 - 2006
- Research FellowJohns Hopkins Hospital - Department of Immunology1997 - 1998
- Research FellowJohns Hopkins Hospital - Department of Neonatology1996 - 1997
Professional Memberships
- Member
- Member
- Member
- American Brachytherapy SocietyMember
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
